• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INVIVE; IMPLANTABLE PACEMAKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INVIVE; IMPLANTABLE PACEMAKER Back to Search Results
Model Number V173
Device Problems Premature Discharge of Battery (1057); Incorrect, Inadequate or Imprecise Result or Readings (1535); Device Displays Incorrect Message (2591)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Code Available (3191)
Event Date 11/14/2019
Event Type  Injury  
Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that the cardiac resynchronization therapy pacemaker (crt-p) showed nine months remaining and then two months later showed it was in safety mode.Boston scientific technical services (ts) discussed pacing will remain, but with no left ventricular (lv) offset and both right ventricular (rv) lead and lv are unipolar configuration.The crt-p was explanted and replaced the following day.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory review of the the cardiac resynchronization therapy pacemaker's (crt-p's) memory found it had never triggered the replacement indicator while implanted.Further review noted that there was a total of nine power on resets that occurred within a three month time frame.The final reset was due to three power on resets which put the device into safety mode.The crt-p passed longevity calculations.The device was put back into primary operation to complete further testing, however it was unable to complete as the device reverted back to safety mode while the test was running due to power on resets.The device passed a series of automated diagnostic testing that verifies the performance of pacing, sensing, and recording functions of the device commensurate with battery voltage.The device case was opened and a battery voltage of 2.792v was noted.The battery was removed and the current drain was within tolerance of the circuit.Further detailed analysis determined the cause of the crt-p going into safety mode was due to a shorted battery.The battery was shorted due to a tube tear.
 
Event Description
This report is being filed to submit the analysis results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INVIVE
Type of Device
IMPLANTABLE PACEMAKER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key9550698
MDR Text Key173711338
Report Number2124215-2019-27125
Device Sequence Number1
Product Code NKE
UDI-Device Identifier00802526536632
UDI-Public00802526536632
Combination Product (y/n)N
PMA/PMN Number
P030005/S079
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 04/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/06/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/05/2014
Device Model NumberV173
Device Catalogue NumberV173
Device Lot Number100394
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/09/2019
Date Manufacturer Received03/17/2020
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age89 YR
-
-